ExcelFin Acquisition Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a XFIN research report →
Price Chart
About the company
ExcelFin Acquisition Corp. currently possesses no substantial ongoing business activities. Its primary objective is to complete a strategic business combination, which may involve a merger, stock swap, asset acquisition, equity purchase, corporate restructuring, or a similar transaction, with one or more other enterprises.
- CEO
- Joseph D. Ragan III
- IPO
- 2021
- Employees
- 4
- HQ
- San Francisco, CA, US
Get TickerSpark's AI analysis on XFIN
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $60.84M
- P/E
- -42.00
- PEG
- 0.36
- P/S
- 0.00
- P/B
- 11.50
- EV/EBITDA
- 0.00
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -2.74%
- ROIC
- -47.98%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+100.0%
- Op Income
- $-7,240,520
- Net Income
- $-3,287,521-627.6%
- EPS
- $-0.22-1113.8%
- OCF Growth
- -303.3%
- FCF Growth
- -303.3%
- 52W High
- $13.52
- 52W Low
- $9.03
- 50D MA
- $10.80
- 200D MA
- $10.91
- Beta
- -0.01
- RSI (14)
- 32
- Avg Volume
- 13.00K
No earnings-call transcripts are available for XFIN yet.
- Free Float
- 100.0%
- Shares Outstanding
- 6.58M
- Float Shares
- 6.58M
of shares held by institutions
11 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Davidson Kempner Partners | 500.00K | ▲ 500.00K |
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 25, 23 | ExcelFin SPAC LLC | other | 5,750,000 |
| May 11, 23 | HIGHBRIDGE CAPITAL MANAGEMENT LLC | sell | 81,175 |
| May 4, 23 | HIGHBRIDGE CAPITAL MANAGEMENT LLC | sell | 310 |
| Apr 28, 23 | HIGHBRIDGE CAPITAL MANAGEMENT LLC | sell | 200 |
| Apr 19, 23 | HIGHBRIDGE CAPITAL MANAGEMENT LLC | other | 0 |
| Oct 20, 21 | ExcelFin SPAC LLC | other | 5,750,000 |
| Oct 20, 21 | Wolfson Neil E | other | 0 |
| Oct 20, 21 | Riley Warren B | other | 0 |
| Oct 20, 21 | Dougan Brady W | other | 0 |
| Oct 20, 21 | Gupta Alka | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our XFIN coverage
Recent articles, reports, and earnings notes.
No research on XFIN yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate XFIN report →Baird Medical and ExcelFin Acquisition Corp Complete Business Combination
prnewswire.com · Oct 1
Baird Medical and ExcelFin Acquisition Corp Announce Effectiveness of Registration Statement
prnewswire.com · Sep 5
Baird Medical and ExcelFin Acquisition Corp Announce Strategic Update to Business Combination Terms to Reinforce Long-Term Value Creation Opportunity and Alignment with Shareholders
prnewswire.com · Mar 12
ExcelFin Acquisition Corp. Announces Adjournment of Special Meeting
prnewswire.com · Oct 17
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.